VYNE compared with YARW: revenue, margins and what each company keeps, and the suppliers and customers both name

VYNEVYNE Therapeutics Inc.

Mkt capRevenueRevenue

YARWYarrow Bioscience, Inc.

Mkt capRevenueRevenue

Compare

VYNEVYNE Therapeutics Inc.

YARWYarrow Bioscience, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

VYNE

Reportimpliedrealized× implied

Aug 14 '26—▼−0.54%—

Jul 29 '26—▲+8.56%—

Nov 6 '25—▲+4.59%—

Aug 14 '25—▲+0.69%—

YARW

No earnings history for YARW.

= impliedVYNE realized, solidYARW realized, hatchedOne scale, both sides: full bar = 9%× = |realized| ÷ impliedSource: market data

VYNEVYNE Therapeutics Inc.

20.42▲+2.10%· post 20.42

Mkt cap—Revenue—Revenue—

YARWYarrow Bioscience, Inc.

20.42▲+2.10%· post 20.42

ClosedOct 30 '26

Mkt cap$53.1MRevenue$97,000Q2 FY26Revenue$501,000FY24

Compare

ClosedOct 30 '26

VYNEVYNE Therapeutics Inc.

YARWYarrow Bioscience, Inc.

20.42▲+2.10%post 20.42

Price

20.42▲+2.10%post 20.42

—

Mkt cap

$53.1M

—

Revenue

$97,000Q2 FY26

—

Revenue

$501,000FY24

VYNE20.42▲+2.10%vsYARW20.42▲+2.10%ClosedOct 30 '26